Receiver in the canal (RIC) hearing aids for Hearing Aids
Study Summary
This study is evaluating whether hearing aids may help reduce tinnitus for individuals with normal hearing.
- Hearing Aids
- Normal Hearing
- Tinnitus
Treatment Effectiveness
Effectiveness Progress
Other trials for Hearing Aids
Study Objectives
1 Primary · 0 Secondary · Reporting Duration: The Tinnitus Functional index will be administered at baseline, 2-3 weeks after baseline, and 3 months after baseline
Trial Safety
Safety Progress
Other trials for Hearing Aids
Trial Design
2 Treatment Groups
VA Clinician Interviews
1 of 2
Hearing Aid Study
1 of 2
35 Total Participants · 2 Treatment Groups
Primary Treatment: Receiver in the canal (RIC) hearing aids · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 5 Total Inclusion Criteria
Mark “yes” if the following statements are true for you:About The Reviewer
Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.
Who else is applying?
What state do they live in?
| Oregon | 88.9% |
| California | 11.1% |
How old are they?
| 18 - 65 | 100.0% |
What site did they apply to?
| VA Portland Health Care System, Portland, OR | 100.0% |
What portion of applicants met pre-screening criteria?
| Met criteria | 100.0% |